ABLD Fundamental Analysis - ABL DIAGNOSTICS

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ABLD. ABLD was compared to 15 industry peers in the Trading Companies & Distributors industry. ABLD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ABLD is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ABLD had positive earnings in the past year.

ABLD had a positive operating cash flow in the past year.

Of the past 5 years ABLD 4 years were profitable.

In the past 5 years ABLD reported 4 times negative operating cash flow.

1.2 Ratios

ABLD's Return On Assets of 1.36% is on the low side compared to the rest of the industry. ABLD is outperformed by 60.00% of its industry peers.

Looking at the Return On Equity, with a value of 2.70%, ABLD is doing worse than 60.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	1.36%
ROE	2.7%
ROIC	N/A

ROA(3y)3.32%

ROA(5y)3.14%

ROE(3y)6.99%

ROE(5y)5.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 3.13%, ABLD is in the better half of the industry, outperforming 66.67% of the companies in the same industry.

The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	3.13%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ABLD has about the same amount of shares outstanding.

ABLD has more shares outstanding than it did 5 years ago.

ABLD has a better debt/assets ratio than last year.

2.2 Solvency

ABLD has an Altman-Z score of 7.45. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.

ABLD's Altman-Z score of 7.45 is amongst the best of the industry. ABLD outperforms 100.00% of its industry peers.

A Debt/Equity ratio of 0.26 indicates that ABLD is not too dependend on debt financing.

ABLD has a better Debt to Equity ratio (0.26) than 73.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Altman-Z	7.45

ROIC/WACCN/A

WACC7.88%

2.3 Liquidity

A Current Ratio of 2.06 indicates that ABLD has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.06, ABLD is in line with its industry, outperforming 60.00% of the companies in the same industry.

ABLD has a Quick Ratio of 1.92. This is a normal value and indicates that ABLD is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.92, ABLD belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.06
Quick Ratio	1.92

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 420.59% over the past year.

Measured over the past years, ABLD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -48.36% on average per year.

The Revenue has decreased by -5.03% in the past year.

EPS 1Y (TTM)420.59%

EPS 3Y-48.36%

EPS 5YN/A

EPS Q2Q%134.78%

Revenue 1Y (TTM)-5.03%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-18.02%

3.2 Future

ABLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.

The Revenue is expected to grow by 41.75% on average over the next years. This is a very strong growth

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year34.37%

Revenue Next 2Y41.75%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 226.00, which means the current valuation is very expensive for ABLD.

66.67% of the companies in the same industry are cheaper than ABLD, based on the Price/Earnings ratio.

When comparing the Price/Earnings ratio of ABLD to the average of the S&P500 Index (27.29), we can say ABLD is valued expensively.

Based on the Price/Forward Earnings ratio of 73.86, the valuation of ABLD can be described as expensive.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ABLD indicates a slightly more expensive valuation: ABLD is more expensive than 73.33% of the companies listed in the same industry.

ABLD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.85.

		Industry Rank	Sector Rank
PE	226
Fwd PE	73.86

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABLD does not grow enough to justify the current Price/Earnings ratio.

ABLD's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.

PEG (NY)2.26

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ABLD has a Yearly Dividend Yield of 1.11%.

ABLD's Dividend Yield is slightly below the industry average, which is at 2.74.

Compared to an average S&P500 Dividend Yield of 2.38, ABLD's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	1.11%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DPN/A

EPS Next 2Y41.42%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ABL DIAGNOSTICS

EPA:ABLD (10/16/2025, 7:00:00 PM)

4.52

-0.02 (-0.44%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryTrading Companies & Distributors

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners99.24%

Ins Owner ChangeN/A

Market Cap72.82M

Analysts85.71

Price Target6.28 (38.94%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.11%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	226
Fwd PE	73.86
P/S	12.34
P/FCF	N/A
P/OCF	91.64
P/B	10.63
P/tB	17.33
EV/EBITDA	N/A

EPS(TTM)0.02

EY0.44%

EPS(NY)0.06

Fwd EY1.35%

FCF(TTM)0

FCFYN/A

OCF(TTM)0.05

OCFY1.09%

SpS0.37

BVpS0.43

TBVpS0.26

PEG (NY)2.26

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.36%
ROE	2.7%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	3.13%
GM	N/A
FCFM	N/A

ROA(3y)3.32%

ROA(5y)3.14%

ROE(3y)6.99%

ROE(5y)5.41%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.43

Health

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	13.8%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.06
Quick Ratio	1.92
Altman-Z	7.45

F-Score5

WACC7.88%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)420.59%

EPS 3Y-48.36%

EPS 5YN/A

EPS Q2Q%134.78%

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-5.03%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-18.02%

Revenue Next Year34.37%

Revenue Next 2Y41.75%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-76.32%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year789.36%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y98.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y61.93%

OCF growth 3YN/A

OCF growth 5YN/A

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens